COVID-19 Trends Spur Cautious Optimism
In today’s Recommendations for Industry, we discuss the cautious optimism spurred by current COVID trends. Read more below. As you’ll see today in our Risk
In today’s Recommendations for Industry, we discuss the cautious optimism spurred by current COVID trends. Read more below. As you’ll see today in our Risk
In today’s Recommendations for Industry, we discuss the question: Is it Safe to Get the COVID-19 & Flu Vaccines at the Same Time? Read more
In today’s Recommendations for Industry, we discuss COVID-19 tests and the updated Risk Matrix (things are getting better). Read more below. Since the White House
In today’s Recommendations for Industry, we discuss a new COVID-19 treatment. Read more below. The most recent report from the American Academy of Pediatrics (AAP)
In today’s Recommendations for Industry, we look at the Mu variant and the Flu Vaccine. Read more below. S. COVID-19 cases have reached 40 million
In today’s Recommendations for Industry, we look at the Risk Matrix. Read more below. In Flu Season News: According to the WHO global flu update
In today’s Recommendations for Industry, we discuss natural immunity from the COVID-19 virus. Read more below. COVID-19 outbreak in California school traced to unvaccinated teacher.
In today’s Recommendations for Industry, we discuss the newly surging COVID questions and stressors of employees and the impact on your business. Read more below.
In today’s Recommendations for Industry, we provide an in-depth look at COVID-19 Variants of Concern and the findings of TAG’s weekly Risk Matrix Analysis. Read
In today’s Recommendations for Industry, we discuss why developed countries, including the U.S., need to see Nigeria’s cholera outbreak as a cautionary warning. Read more